ISRCTN85334402已完成不适用

Double-blind randomized controlled trial to evaluate the efficacy of cell therapy based on autologous platelet-rich plasma (PRP) for the treatment of Achilles and patellar tendinopathies

niversity Hospital Complex of Vaud (Centre Hospitalier Universitaire Vaudois [CHUV]) (Switzerland)0 个研究点目标入组 128 人开始时间: 2013年11月11日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. History (> 6 weeks) of exercise-associated pain along the proximal insertion of the patellar tendon or the Achilles tendon
•2. Being at least 18 and no more than 60 years old, either sex
•3. Radiologic confirmation of the tendinopathy (MRI or ultrasound)
•4. Patient who has signed an informed consent

•1. Absence of informed consent/participation in some other clinical trial
•2. Presence of inflammatory?rheumatoid or systemic conditions
•3. Presence or history of complications of important lower limb injuries
•4. Presence of acute affections of the lower limb (i.e., infection, tendon rupture)
•5. Patients requiring non-steroidal anti-inflammatory drug (NSAID) treatment for other type of affections
•6. Patients undergoing medical treatment that could inhibit tendinopathies (i.e., fluoroquinolones)

发起方

niversity Hospital Complex of Vaud (Centre Hospitalier Universitaire Vaudois [CHUV]) (Switzerland)